Position in GERN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,135
+$1,955 QoQ
Shares Held
11,500
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $221,188,371 across 29 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
368,978 | $105,147,660 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,845 | $32,950,970 | |
| 3 | INCY |
Incyte Corp
|
224,855 | $25,489,561 | |
| 4 | EXEL |
Exelixis, Inc.
|
437,138 | $23,784,676 | |
| 5 | INVA |
Innoviva, Inc.
|
274,391 | $6,231,419 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
38,672 | $2,880,290 | |
| 7 | ASND |
Ascendis Pharma A/S
|
10,735 | $2,863,239 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
8,550 | $2,702,569 |
All Filings in GERN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,135 | 11,500 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,180 | 11,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $15,755 | 11,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,215 | 11,500 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $18,285 | 11,500 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $40,710 | 11,500 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,210 | 11,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $48,760 | 11,500 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||